Alnylam Pharmaceuticals, Inc.
DE ˙ XTRA ˙ US02043Q1076
260,50 € ↑8,70 (3,46%)
2026-06-04
DEL PRIS
SecurityDE:DUL / Alnylam Pharmaceuticals, Inc.
InstitutionDAVENPORT & Co LLC
Latest Disclosed Ownership1,842 shares
Latest Disclosed Value $ 609,463
DAVENPORT & Co LLC ownership in DUL / Alnylam Pharmaceuticals, Inc.

On April 15, 2026 - DAVENPORT & Co LLC filed a 13F-HR form disclosing ownership of 1,842 shares of Alnylam Pharmaceuticals, Inc. (DE:DUL) valued at $526,259 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 12, 2026 disclosing 1,759 shares of Alnylam Pharmaceuticals, Inc.. This represents a change in shares of 4.72% during the quarter. The current value of the position is $479,841 USD.

DAVENPORT & Co LLC has a history of taking positions in derivatives of the underlying security (DUL) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:DUL / Alnylam Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-15 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 1,842 83 4.72 609 -12.88 0.0033
2026-01-12 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 1,759 1,759 699 0.0037
2022-05-02 2022-03-31 13F/A-1 ALNY COM 02043Q107 0 -3,705 -100.00 0 -100.00
2022-05-02 2022-03-31 13F ALNY COM 02043Q107 0 0
2022-02-10 2021-12-31 13F ALNY COM 02043Q107 3,705 288 8.43 628 -2.64 0.0041
2021-10-14 2021-09-30 13F ALNY COM 02043Q107 3,417 533 18.48 645 31.90 0.0046
2021-07-28 2021-06-30 13F/A-2 ALNYLAM PHARMACEUTICALS COM 02043Q107 2,884 2,884 489 0.0038
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-10-14 2021-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-07-21 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 2,884 489 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.